The medical dynamometers market is predicted to surge owing to the rise in bone-related conditions like osteoporosis and arthritis, along with an uptick in sports injuries and the expanding elderly demographic.
LAS VEGAS, April 30, 2024 /PRNewswire/ -- DelveInsight's Medical Dynamometers Market Insights report provides the current and forecast market analysis, individual leading medical dynamometers companies' market shares, challenges, medical dynamometers market drivers, barriers, trends, and key market medical dynamometers companies in the market.
Key Takeaways from the Medical Dynamometers Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global medical dynamometers market during the forecast period.
- Notable medical dynamometers companies such as Charder Electronic Co, Ltd., JTECH Medical Industries, KERN & SOHN GmbH, Biodex Medical Systems, Inc., North Coast Medical Inc., B&L Engineering, JLW Instruments, Bharat Medical Systems, Fabrication Enterprises, Lafayette Instrument Company, EASYCARE, Hausmann Industries, Kinvent, Bio-sensing Solutions SL, BIOMETRICS LTD, Marsden Weighing Machine Group, Sensyteq, Dynatron Corporation, TruMedical Solutions LLC, Physio Care Devices, and several others, are currently operating in the medical dynamometers market.
- In December 2021, JTECH Medical Industries was acquired by ADDvise. Additionally, both companies also entered into a share purchase agreement.
- In January 2019, ActivBody launched Activforce, which is a digital dynamometer portal that helps clinicians to access accurate data.
To read more about the latest highlights related to the medical dynamometers market, get a snapshot of the key highlights entailed in the Global Medical Dynamometers Market Report
Medical Dynamometers Overview
Medical dynamometers are essential tools used in healthcare settings to measure the strength and function of muscles. These devices come in various forms, including hand-held dynamometers, hydraulic dynamometers, and digital dynamometers, each tailored to specific clinical needs. By quantifying muscle strength, medical professionals can assess patients' physical capabilities, monitor progress during rehabilitation, and diagnose muscular impairments or injuries accurately. Additionally, medical dynamometers provide objective data, enabling clinicians to tailor treatment plans and interventions precisely, leading to more effective patient care and improved outcomes.
Furthermore, advancements in medical dynamometry technology have led to increased accuracy, reliability, and ease of use in clinical practice. Modern dynamometers often feature digital displays, ergonomic designs, and wireless connectivity, allowing for real-time data collection and analysis. This enhanced functionality not only streamlines assessment procedures but also facilitates remote monitoring and telehealth consultations, expanding access to quality healthcare services. With their versatility and precision, medical dynamometers continue to play a pivotal role in enhancing musculoskeletal assessment and rehabilitation practices across various medical specialties.
Medical Dynamometers Market Insights
In 2023, North America led the medical dynamometers market among all regions, mainly because of its large population dealing with arthritis and osteoporosis. This dominance is fueled by several factors, including a significant number of sports-related injuries, a growing elderly population, and the region's advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC) in 2023, approximately 53.2 million people in the United States were diagnosed with various bone disorders such as arthritis, rheumatoid arthritis, and gout between 2019 and 2021. This prevalence necessitates better management and treatment, thus boosting the demand for medical dynamometers, particularly in the United States.
Additionally, a study published in the American Academy of Orthopedic Surgeons in 2023 highlighted a substantial number of sports injuries among high school athletes in the United States from 2015 to 2019. This surge in sports-related injuries further contributes to the growth of the Medical Dynamometers Market in the United States, consequently influencing the overall medical dynamometers market in North America positively during the forecast period.
To know more about why North America is leading the market growth in the medical dynamometers market, get a snapshot of the Medical Dynamometers Market Outlook
Medical Dynamometers Market Dynamics
The medical dynamometers market dynamics reflect a blend of technological advancements, growing healthcare infrastructure, and increasing emphasis on rehabilitation and physical therapy. With a rising global geriatric population and a surge in chronic conditions such as musculoskeletal disorders, the demand for medical dynamometers continues to escalate. These devices, designed to measure muscle strength and assess physical performance, are witnessing heightened adoption across hospitals, rehabilitation centers, and sports medicine facilities.
Furthermore, the integration of digital health solutions and IoT technology is revolutionizing the medical dynamometer landscape. Advanced dynamometers equipped with wireless connectivity and cloud-based data storage capabilities offer real-time monitoring and analysis of patient progress. This convergence of healthcare and technology not only enhances diagnostic accuracy but also facilitates personalized treatment plans, driving market growth and innovation.
However, challenges such as high costs associated with advanced dynamometers and limited reimbursement policies in certain regions could impede medical dynamometer market expansion. Nevertheless, strategic collaborations between medical device manufacturers and healthcare providers, coupled with ongoing research and development initiatives, are anticipated to mitigate these challenges and foster sustainable growth in the medical dynamometers market. As the focus on preventive healthcare and rehabilitation intensifies, the market is poised for continuous evolution, catering to the diverse needs of patients and healthcare professionals alike.
Get a sneak peek at the medical dynamometers market dynamics @ Medical Dynamometers Market Dynamics Analysis
Report Metrics | Details |
Coverage | Global |
Study Period | 2021-2030 |
Medical Dynamometers Market CAGR | ~6% |
Medical Dynamometers Market Size by 2030 | USD 820.57 Million |
Key Medical Dynamometers Companies | Charder Electronic Co, Ltd., JTECH Medical Industries, KERN & SOHN GmbH, Biodex Medical Systems, Inc., North Coast Medical Inc., B&L Engineering, JLW Instruments, Bharat Medical Systems, Fabrication Enterprises, Lafayette Instrument Company, EASYCARE, Hausmann Industries, Kinvent, Bio-sensing Solutions SL, BIOMETRICS LTD, Marsden Weighing Machine Group, Sensyteq, Dynatron Corporation, TruMedical Solutions LLC, Physio Care Devices, among others |
Medical Dynamometers Market Assessment
- Medical Dynamometers Market Segmentation
- Medical Dynamometers Market Segmentation By Product: Chest Dynamometer, Hand Dynamometer, Push Pull Dynamometer, and Others
- Medical Dynamometers Market Segmentation By Application: Orthopedic, Cardiology, Neurology, Medical Trauma, and Others
- Medical Dynamometers Market Segmentation By End User: Hospitals and Clinics, Rehabilitation Centers, and Others
- Medical Dynamometers Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the medical dynamometers market are set to emerge as the trendsetter explore @ Medical Dynamometers Companies
Table of Contents
1 | Report Introduction |
2 | Executive summary |
3 | Regulatory and Patent Analysis |
4 | Key Factors Analysis |
5 | Porter's Five Forces Analysis |
6 | Medical Dynamometers Market Layout |
7 | Global Company Share Analysis - Key 3-5 Companies |
8 | Medical Dynamometers Market Company and Product Profiles |
9 | Project Approach |
10 | About DelveInsight |
Interested in knowing the medical dynamometers market by 2030? Click to get a snapshot of the Medical Dynamometers Market Trends
Related Reports
Knee Osteoarthritis Pipeline
Knee Osteoarthritis Pipeline Insight - 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key knee osteoarthritis companies, including Bone Therapeutics, Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics, Centrexion Therapeutics, Taiwan Liposome Company, Techfields Pharma, AstraZeneca, Ampio Pharmaceuticals, BioIntegrate, Sorrento Therapeutics, Swiss Medica XXI Century S.A., OrthoTrophix, Amzell, Eupraxia Pharmaceuticals, Meluha Life Sciences, Vivex Biomedical, Orient Europharma Co., Ltd., Paradigm Biopharmaceuticals, Abbvie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, Eupraxia Pharmaceuticals, Celltex Therapeutics Corporation, Eli Lilly and Company, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Propella Therapeutics, Biosplice Therapeutics, Jiangsu XinChen-Techfields Pharma Co., LTD., Teva Pharmaceutical Industries, Pfizer, Grünenthal GmbH, PMG Pharm Co., Ltd, Nordic Bioscience A/S, BUZZZ Pharmaceuticals Limited, Antibe Therapeutics, Saol Therapeutics Inc, LG Chem, among others.
Osteoarthritis Market
Osteoarthritis Market Insights, Epidemiology, and Market Forecast - 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key osteoarthritis companies including Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen, Personalized Stem Cells, Peptinov, Asahi Kasei Pharma, Taiwan Bio Therapeutics, OliPass Corporation, Bioventus, Medipost, Moebius Medical, ReqMed, TissueTech, Novartis, AstraZeneca, Biosplice Therapeutics, Cynata Therapeutics, Bone Therapeutics S.A, Regeneron Pharmaceuticals, Techfields Pharma, Ampio Pharmaceuticals, Taiwan Liposomal Company, K-STEMCELL, Stempeutics, Levolta Pharmaceuticals, among others.
Osteoarthritis Pipeline
Osteoarthritis Pipeline Insight - 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key osteoarthritis companies, including Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen, Personalized Stem Cells, Peptinov, Asahi Kasei Pharma, Taiwan Bio Therapeutics, OliPass Corporation, Bioventus, Medipost, Moebius Medical, ReqMed, TissueTech, Novartis, AstraZeneca, Biosplice Therapeutics, Cynata Therapeutics, Bone Therapeutics S.A, Regeneron Pharmaceuticals, Techfields Pharma, Ampio Pharmaceuticals, Taiwan Liposomal Company, K-STEMCELL, Stempeutics, Levolta Pharmaceuticals, among others.
Erosive Hand Osteoarthritis
Erosive Hand Osteoarthritis Pipeline Insight - 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key erosive hand osteoarthritis companies, including Paradigm Biopharmaceuticals, Abbvie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-medical-dynamometers-market-to-witness-upsurge-in-growth-at-a-cagr-of-6-by-2030--delveinsight-302131109.html
